Jul 22, 2026 03:58AM
Jul 20, 2026 03:19AM
Jul 16, 2026 04:44PM
Jul 1, 2026 07:00AM
Jun 29, 2026 07:05AM
Jun 25, 2026 06:49AM
Jun 24, 2026 07:05AM RegenxBio completes dosing in RGX-202 confirmatory Duchenne study
Jun 23, 2026 06:51AM
Jun 22, 2026 10:21AM
Jun 22, 2026 09:50AM
Jun 22, 2026 07:31AM
Jun 22, 2026 06:43AM
Jun 8, 2026 06:54AM
May 27, 2026 09:13AM Stifel Reiterates Buy Rating on Regenxbio Inc. (RGNX)
May 15, 2026 04:56AM
May 14, 2026 07:12AM
Mar 12, 2026 05:14AM
Mar 11, 2026 11:51AM
Mar 9, 2026 07:46AM
Mar 9, 2026 06:49AM
Mar 6, 2026 08:20AM Regenxbio Inc. (RGNX) PT Lowered to $18 at Leerink Partners
Mar 5, 2026 05:17PM
Mar 5, 2026 02:52PM
Mar 5, 2026 02:11PM
Mar 5, 2026 07:06AM
Feb 26, 2026 11:53AM
Feb 11, 2026 06:40AM
Feb 10, 2026 06:32AM Regenxbio Inc. (RGNX) PT Lowered to $12 at Goldman Sachs
Feb 9, 2026 04:41PM
Feb 9, 2026 04:05PM
Feb 9, 2026 04:01PM
Jan 29, 2026 06:50AM
Jan 29, 2026 04:44AM
Jan 29, 2026 04:26AM
Jan 28, 2026 01:51PM Stifel on Regenxbio Inc. (RGNX): PT $45, 'should NOT impact RGX-202 and RGX-314'
Jan 28, 2026 07:30AM
Jan 12, 2026 06:53AM
Jan 12, 2026 04:00AM
Jan 7, 2026 09:00PM
Dec 19, 2025 07:44AM
Dec 15, 2025 06:20AM
Nov 26, 2025 04:17PM Regenxbio (RGNX) files mixed shelf
Nov 6, 2025 07:22AM
Oct 30, 2025 07:05AM
Oct 7, 2025 06:45AM
Oct 6, 2025 07:05AM
Sep 8, 2025 07:14AM
Sep 5, 2025 03:21PM
Sep 5, 2025 11:03AM Raymond James on Regenxbio Inc. (RGNX): 'we think FDA guidance is strongly supportive of HS D2S6 as a biomarker'
Sep 5, 2025 07:05AM

421,598 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All